Literature DB >> 3529673

Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.

J A Anthoons, E A Van Marck, P L Gigase.   

Abstract

Sera from rats with chronic Trypanosoma brucei gambiense infection were tested for autoantibodies by an indirect immunofluorescence assay. All the sera contained IgM autoantibodies which reacted with blood vessel walls. On cultured vascular smooth muscle cells positive sera reacted with cytoplasmic filaments which were rearranged into perinuclear coils of filaments in colcemid-pretreated smooth muscle cells. These observations strongly suggest that the cytoplasmic autoantigens are intermediate filaments (I.F.). It is probable that the anti-intermediate filament autoantibodies result from polyclonal lymphocyte activation, since in rats experimentally infected with T.b. gambiense the appearance of these autoantibodies occurs already 1 week post-infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3529673     DOI: 10.1007/bf00927888

Source DB:  PubMed          Journal:  Z Parasitenkd        ISSN: 0044-3255


  33 in total

1.  Immunofluorescent tracing of smooth muscle contractile protein antigens in tissues other than smooth muscle.

Authors:  P Trenchev; P Sneyd; E J Holborow
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

2.  Autoimmune response to DNA, red blood cells, and thymocyte antigens in association with polyclonal antibody synthesis during experimental African trypanosomiasis.

Authors:  T Kobayakawa; J Louis; S Izui; P H Lambert
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

Review 3.  The detection of human antibodies against cytoskeletal components.

Authors:  P Kurki; I Virtanen
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

4.  Experimental infection with two stocks of Trypanosoma brucei gambiense. Study of the evolution by elution techniques of tissues.

Authors:  P M Mulumba; M Wéry
Journal:  Contrib Microbiol Immunol       Date:  1983

Review 5.  The pathogenesis of sleeping sickness.

Authors:  B M Greenwood; H C Whittle
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

6.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

7.  Smooth muscle autoantibodies in infectious mononucleosis.

Authors:  E J Holborow; E H Hemsted; S V Mead
Journal:  Br Med J       Date:  1973-08-11

8.  Autoimmunity in experimental Trypanosoma congolense infections of rabbits.

Authors:  J M Mansfield; J P Kreier
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

9.  Antibody to intermediate filaments of the cytoskeleton in the sera of patients with acute malaria.

Authors:  S M Mortazavi-Milani; S S Badakere; E J Holborow
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  The presence of antibody to a normal rabbit liver antigen in rabbits infected with Trypanosoma gambiense.

Authors:  J R Seed; A A Gam
Journal:  J Parasitol       Date:  1967-10       Impact factor: 1.276

View more
  3 in total

1.  Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African trypanosomiasis.

Authors:  Bertrand Courtioux; Sylvie Bisser; Pascal M'belesso; Edgard Ngoungou; Murielle Girard; Auguste Nangouma; Théophile Josenando; Marie-Odile Jauberteau-Marchan; Bernard Bouteille
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

Authors:  M Girard; S Bisser; P Buscher; B Bouteille; J L Preud'homme; M O Jauberteau
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

3.  Immunophenotypic lymphocyte profiles in human african trypanosomiasis.

Authors:  Caroline Boda; Bertrand Courtioux; Pierre Roques; Lynda Pervieux; Gédéon Vatunga; Théophile Josenando; Constant Roger Ayenengoye; Bernard Bouteille; Marie-Odile Jauberteau; Sylvie Bisser
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.